HIGHLIGHTS
- who: Satoshi Yamasaki and colleagues from the Institute Retrospective Department of Internal Medicine, Kyushu University Beppu Hospital, Tsurumihara, Beppu, Japan have published the article: Bisphosphonate Use for Glucocorticoid-Induced Osteoporosis in Elderly Patients with Immune Thrombocytopenia Receiving Prolonged Steroid Therapy: A Single Institute Retrospective Study, in the Journal: (JOURNAL)
SUMMARY
With regard to jurisdictional claims in Glucocorticoid therapy is the standard initial treatment for immune thrombocytopenia (ITP) and is an important risk factor for osteoporosis. In Japan, Helicobacter pylori eradication is considered before initial prednisolone therapy for ITP. Alterations in immune homeostasis in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.